Petco Health and Wellness Company, Inc. WOOF
2.27
(0.02)
(0.87%)
as of 25 Sep
- Market cap
- $641.6M
- P/E
- 20.6×
Follow WOOF
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 90.67 | 142.00 | 25.36 |
P/S ratio |
0.15 | 0.13 | 0.14 | 0.13 | |
P/FCF ratio |
6.74 | 4.01 | 4.94 | 3.35 | |
P/Operating CF |
9.90 | 4.95 | (26.02) | 4.93 | |
P/B ratio |
0.77 | 0.65 | 0.70 | 0.66 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.37 | 0.33 | 0.35 | 0.33 | |
EV/EBITDA |
7.04 | 6.20 | 6.42 | 5.90 | |
EV/Operating CF |
8.74 | 6.36 | 7.09 | 5.29 | |
EV/FCF |
16.94 | 10.54 | 12.99 | 8.32 | |
Quick Ratio |
0.25 | 0.27 | 0.18 | 0.28 | |
Current Ratio |
0.91 | 0.90 | 0.85 | 0.90 | |
Net Debt/EBITDA |
16.92 | 15.20 | 17.48 | 11.87 | |
Debt/Assets |
30.49% | 28.86% | 29.06% | 28.56% | |
Debt/Equity |
1.37 | 1.28 | 1.28 | 1.22 | |
Asset Turnover |
1.15 | 1.15 | 1.17 | 1.16 | |
Operating CF/Net income |
9.66 | (59.62) | 2.04 | 4.18 | |
Capex/Depreciation |
(0.58) | (0.75) | (0.76) | (0.61) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
36.86% | 36.23% | 36.73% | 36.48% | |
Intangible Assets out of Total Assets |
0.39 | 0.39 | 0.39 | 0.39 | |
Share Based Compensation of Revenue |
0.49% | 0.48% | 0.63% | 0.58% | |
Graham Net Nets |
(3.41) | (3.93) | (3.68) | (3.65) | |
Graham Number |
0.00 | 1.68 | 1.35 | 3.23 | |
Earnings Yield |
(0.31%) | 1.10% | 0.70% | 3.94% | |
Free Cash Flow Yield |
14.83% | 24.92% | 20.23% | 29.86% | |
Revenue per Share |
5.22 | 5.42 | 5.28 | 5.21 | |
Operating CF per Share |
0.32 | 0.55 | (0.11) | 0.57 | |
Capex per Share |
(0.10) | (0.13) | (0.13) | (0.11) | |
Free Cash Flow per Share |
0.22 | 0.42 | (0.24) | 0.45 | |
Cash per Share |
0.85 | 0.92 | 0.59 | 1.03 | |
Shareholders Equity per Share |
4.13 | 4.16 | 4.07 | 4.23 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.13 | 4.16 | 4.07 | 4.23 | |
Free Cash Flow |
60.76 | 116.39 | (69.12) | 129.92 | |
Working Capital |
(96.06) | (114.35) | (169.42) | (113.35) | |
Capital Expenditures |
(29.33) | (37.14) | (38.15) | (31.63) | |
Net Current Asset Value |
(3,040.13) | (2,989.38) | (2,968.44) | (2,906.62) | |
EV/EBIT |
21.15 | 16.58 | 16.44 | 14.82 | |
Capex to Sales |
0.02 | 0.02 | 0.03 | 0.02 | |
Net Profit Margin |
0.64% | (0.17%) | (1.01%) | 2.60% | |
Price to Operating Income |
8.41 | 6.31 | 6.26 | 5.97 | |
| Other line items | |||||
Average Receivables |
41.67 | 43.12 | 36.50 | 36.46 | |
Average Payables |
438.83 | 471.72 | 477.28 | 439.29 | |
Average Inventory |
654.09 | 621.77 | 639.19 | 605.05 | |
Average Assets |
5,208.30 | 5,183.93 | 5,102.86 | 5,159.97 | |
Average Common Equity |
1,140.22 | 1,138.94 | 1,131.32 | 1,173.02 |
Columns are period end dates